<DOC>
	<DOCNO>NCT01404936</DOCNO>
	<brief_summary>This clinical research study interferon ( IFN ) plus chemotherapy standard combination Adriamycin , Bleomycin , Velban , Dacarbazine ( ABVD ) . The treatment give patient Hodgkin 's disease . The study look whether add IFN ABVD improve immune response Hodgkin 's disease , determine whether toxicity ABVD increase add IFN .</brief_summary>
	<brief_title>Study a-Interferon With Adriamycin , Bleomycin , Velban , Dacarbazine ( ABVD ) With Hodgkin 's Disease</brief_title>
	<detailed_description>Each treatment cycle last 2 week . On day 1 - 4 cycle , patient give shot IFN skin . On day 4 , patient give ABVD vein one-hour . The plan patient receive 12 cycle treatment . However , patient leave study severe side effect cancer grow spread . They also leave cancer improve 6 cycle . Patient leave study offer treatment . A maximum 35 patient treat dose . Before first treatment , patient physical exam , blood test , heart scan . Within 1 month start treatment , patient chest X-ray , CT scan abdomen pelvis , gallium scan . During study , patient blood test every week physical exam every 2 week . The X-ray , CT scan , gallium scan repeat cycle 6 12 . All drug study approve U.S. Food Drug Administration available prescription . ABVD standard treatment Hodgkin 's disease ; IFN investigational treatment Hodgkin 's disease . About 35 patient enrol study . All treatment give outpatient clinic M.D . Anderson Cancer Center .</detailed_description>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>1 . Hodgkin 's disease patient relapse radiation therapy alone , combination Novantrone , Oncovin , Velban , Prednisone ( NOVP ) ; previously untreated patient stage III IV eligible standard ABVD therapy . 2 . Must adequate bone marrow reserve Absolute neutrophil count ( ANC ) &gt; 1,000/uL , Platelets &gt; 100,000 3 . Left ventricular ejection fraction ( LVEF ) &gt; /= 50 % , serum creatinine &lt; 2mg/dl , serum bilirubin &lt; 2mg/dl 1 . No prior therapy Mustargen Oncovin Procarbazine Prednisone ( MOPP ) . 2 . No severe pulmonary disease include Chronic obstructive pulmonary disease ( COPD ) asthma .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Lymphoma</keyword>
	<keyword>Hodgkin 's Disease</keyword>
	<keyword>Stage III IV</keyword>
	<keyword>Adriamycin</keyword>
	<keyword>Doxorubicin</keyword>
	<keyword>Rubex</keyword>
	<keyword>Bleomycin</keyword>
	<keyword>Bleomycin Sulfate</keyword>
	<keyword>BLM</keyword>
	<keyword>Dacarbazine</keyword>
	<keyword>DTIC-DOME</keyword>
	<keyword>Interferon-2A</keyword>
	<keyword>Interferon-Alfa-2a</keyword>
	<keyword>Roferon-A</keyword>
	<keyword>Velban</keyword>
	<keyword>Vinblastine</keyword>
</DOC>